Source: News-Medical, 14 May 2026
An international team led by Professor Samuele Cortese of the University of Southampton analysed 113 clinical trials involving more than 25,000 people taking five common ADHD medicines. Published in The Lancet Psychiatry, the study found that doses that are too low may not work well, while going above licensed maximum doses did not improve results on average and was linked to more side effects. Decisions about medication should always be made with the treating doctor.
Read the full story at News-Medical
This is a short report on news published elsewhere, written by the Australian Autism ADHD Foundation. Including it here is not an endorsement. For advice about your own situation, please speak with a qualified health professional.